FDA Approved: ACETAZOLAMIDE EXTENDED-RELEASE — Supplemental Application (Micro Labs Limited)

View source ↗

Summary

FDA approved a supplemental application from Micro Labs Limited for an extended-release formulation of acetazolamide.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Altitude Sickness
• Edema Associated with Congestive Heart Failure
• Epilepsy
• Glaucoma
• Idiopathic Intracranial Hypertension

Drugs mentioned

• Acetazolamide Extended-Release (acetazolamide)

Snippet

SUPPL AP for ACETAZOLAMIDE EXTENDED-RELEASE (ACETAZOLAMIDE EXTENDED-RELEASE)